Euclises Pharmaceuticals
Euclises Pharmaceuticals, Inc. is a drug discovery and development company advancing Euclicoxibs®, novel cyclooxygenase-2 (COX-2) inhibitors with superior efficacy for cancer therapy. The company's mission is to harness the clinical power of this validated oncology target to offer new treatment options to cancer patients. They have assembled a team of pharmaceutical veterans with deep expertise in oncology drug development and a management team with extensive experience in the discovery and development of several COX-2 inhibitors, including the blockbuster celecoxib.